Research Article

IL23R and IL12B SNPs and Haplotypes Strongly Associate with Crohn's Disease Risk in a New Zealand Population

Table 2

Genotype and allele counts for IL-12B and IL-23R variants in CD patients and in Caucasian controls.

Control (%)Case (%)OR (95% CI)

IL-12B C/C10 (2.9)11 (3.6)1.30 (0.54–3.12).638
rs1363670C/G71 (20.8)70 (23.3)1.17 (0.80–1.70)
G/G260 (76.3)220 (73.1)1.00
HWE0.100.08
Cochran-Armitage Trend for G , 0.172
C91 (13.3)92 (15.3)1.17 (0.86–1.60).338
G591 (86.7)510 (84.7)1.00

IL-12B C/C39 (10.8)29 (9.2)0.79 (0.47–1.35).625
rs6887695C/G177 (48.9)148 (47.1)0.89 (0.65–1.23)
G/G146 (40.3)137 (43.6)1.00
HWE0.210.25
C255 (35.2)206 (32.8)0.90 (0.72–1.13).358
G469 (64.8)422 (67.2)1.00

IL-23RA/A45 (12.5)37 (11.8)1.18 (0.72–1.93).030
rs10889677A/C146 (40.6)158 (50.5)1.55 (1.12–2.15)
C/C169 (46.9)118 (37.7)1.00
HWE0.150.18
A236 (32.8)232 (37.1)1.21 (0.96–1.52).100
C484 (67.2)394 (62.9)1.00

IL-23RA/A5 (0.8)0 (0)
rs11209026A/G75 (11.9)28 (8.0)0.64 (0.41–1.01).164
G/G553 (87.4)321 (92.0)1.00
HWE0.191.00
Cochran-Armitage Trend for G , 0.008
A85 (6.7)28 (4.0)0.58 (0.37–0.90).015
G1181 (93.3)670 (96.0)1.00

IL-23RC/C173 (47.3)123 (39.3)1.00.108
rs11805303C/T158 (43.2)153 (48.9)1.36 (0.99–1.88)
T/T35 (9.6)37 (11.8)1.49 (0.89–2.49)
HWE1.000.33
T228 (31.1)227 (36.3)1.26 (1.01–1.58).049
C504 (68.9)399 (63.7)1.00

IL-23RA/A56 (15.2)16 (5.1)0.29 (0.16–0.53).0002
rs1343151A/G154 (41.7)142 (45.4)0.95 (0.69–1.30)
G/G159 (43.1)155 (49.5)1.00
HWE0.070.02
Cochran-Armitage Trend for G , 0.0006
A266 (36.0)174 (27.8)0.68 (0.54–0.86).001
G472 (64.0)452 (72.2)1.00

IL-23RG/G72 (19.6)29 (9.4)0.42 (0.25–0.70).001
rs7517847G/T183 (49.7)172 (55.7)0.98 (0.70–1.38)
T/T113 (30.7)108 (34.9)1.00
HWE0.920.001
G327 (44.4)230 (37.2)0.74 (0.59–0.92).007
T409 (55.6)388 (62.8) 1.00